Healthy Extracts (HYEX) Long-Term Deferred Tax (2015 - 2016)
Healthy Extracts (HYEX) posted quarterly Long-Term Deferred Tax of $408700.0 for Q4 2016, up 154.17% year-over-year from $160800.0 in Q1 2016, and up 154.17% quarter-over-quarter from $160800.0 in Q4 2015.
Healthy Extracts (HYEX) Long-Term Deferred Tax (2015 - 2016) Analysis & Trends
Healthy Extracts' Long-Term Deferred Tax history runs 2 years deep, the most recent figure standing at $408700.0 for Q4 2016.
- In Q4 2016, Long-Term Deferred Tax rose 154.17% year-over-year to $408700.0; the TTM figure through Dec 2016 stood at $408700.0 (up 154.17% YoY), while the FY2016 annual figure was $408700.0, up 154.17% from the prior year.
- Long-Term Deferred Tax for Q4 2016 stood at $408700.0, up from $160800.0 in the prior quarter.
- The five-year high for Long-Term Deferred Tax was $408700.0 in Q4 2016, with the low at $160800.0 in Q4 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Healthy Extracts | 19.90 Mn | 19.71 Mn | 1.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 408,700.00 |
| Dec 31, 2015 | 160,800.00 |